Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Kingella kingae Tenosynovitis: No Need for Surgical Management?

Kingella kingae Tenosynovitis: No Need for Surgical Management? Letters to the Editor The Pediatric Infectious Disease Journal • Volume 41, Number 7, July 2022 TABLE 1. Demographic, Clinical, Diagnostic and Treatment Data of Patients Case 1 Case 2 Case 3 Case 4 Case 5 General data Gender Male Female Male Male Female Birth age (wks) 38 39 38 34 40 Comorbidities None None None None None Age (d) 13 91 23 36 32 Date November 15, 2021 November 18, 2021 November 19, 2021 January 28, 2022 February 2, 2022 Apnea (duration) November 15–17, 2021 November 18, 2021 November 20–22, 2021 January 28–29, 2022 February 2–March 2, 2022 Fever/cough +/+ +/+ +/+ +/+ –/– Diagnostic procedures SARS-CoV-2 + + + + + Respiratory viruses – – – – – BP/BPP – – – – – Chest radiograph Normal Normal Normal Normal Normal Cranial ultrasonography Normal Not done Normal IVH Normal Transthoracic PFO Not done Normal Normal Normal echocardiography Treatment (d) Oxygen 6 1 1 – – Aminophylline 6 – 4 – – *PCR from NP swab. †Multiplex PCR from NP aspirate for influenza A/B, human metapneumovirus, respiratory syncytial virus, bocavirus, adenovirus, enterovirus, coronaviruses, parainfluenza virus types 1, 2, 3, and 4, parechoviruses and rhinoviruses. ‡PCR from NP aspirate http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Pediatric Infectious Disease Journal Wolters Kluwer Health

Kingella kingae Tenosynovitis: No Need for Surgical Management?

Download PDF
2 pages

Loading next page...
 
/lp/wolters-kluwer-health/kingella-kingae-tenosynovitis-no-need-for-surgical-management-bQSUPagqsm

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
1532-0987
eISSN
0891-3668
DOI
10.1097/inf.0000000000003547
Publisher site
See Article on Publisher Site

Abstract

Letters to the Editor The Pediatric Infectious Disease Journal • Volume 41, Number 7, July 2022 TABLE 1. Demographic, Clinical, Diagnostic and Treatment Data of Patients Case 1 Case 2 Case 3 Case 4 Case 5 General data Gender Male Female Male Male Female Birth age (wks) 38 39 38 34 40 Comorbidities None None None None None Age (d) 13 91 23 36 32 Date November 15, 2021 November 18, 2021 November 19, 2021 January 28, 2022 February 2, 2022 Apnea (duration) November 15–17, 2021 November 18, 2021 November 20–22, 2021 January 28–29, 2022 February 2–March 2, 2022 Fever/cough +/+ +/+ +/+ +/+ –/– Diagnostic procedures SARS-CoV-2 + + + + + Respiratory viruses – – – – – BP/BPP – – – – – Chest radiograph Normal Normal Normal Normal Normal Cranial ultrasonography Normal Not done Normal IVH Normal Transthoracic PFO Not done Normal Normal Normal echocardiography Treatment (d) Oxygen 6 1 1 – – Aminophylline 6 – 4 – – *PCR from NP swab. †Multiplex PCR from NP aspirate for influenza A/B, human metapneumovirus, respiratory syncytial virus, bocavirus, adenovirus, enterovirus, coronaviruses, parainfluenza virus types 1, 2, 3, and 4, parechoviruses and rhinoviruses. ‡PCR from NP aspirate

Journal

The Pediatric Infectious Disease Journal – Wolters Kluwer Health

Published: Jul 7, 2022

There are no references for this article.